BALTIMORE, MD, August 8, 2018 – Paragon Bioservices, the leading private equity-backed biologics contract development and manufacturing organization (CDMO) with proven expertise in gene therapy and next-generation vaccines, announces today two key leadership promotions. Deborah Wild has been promoted from Vice President, Quality, Validation and Regulatory Affairs to Senior Vice President, Quality, Validation and Regulatory Affairs, and Ruby Hofmann has been promoted from Vice President, Human Resources and Organizational Development to Senior Vice President, Human Resources, and Organizational Development.
“As Paragon Bioservices continues its track record of rapid growth, we’re strengthening our leadership ranks with the promotions of Deborah Wild and Ruby Hofmann. These promotions reflect each of their contributions to Paragon: they are exceptional leaders who have been instrumental in the current success of Paragon and will play important roles in driving future successes,” said President and CEO of Paragon Bioservices Pete Buzy. “Deb has led the charge in defining our Quality Philosophy and has been a key driver in the BWI expansion project. Ruby has revamped our HR function by formalizing the talent acquisition team and evolving our corporate culture.”
Click here to read the entire press release.